Trademark: 85893345
Word
SCRI DEVELOPMENT INNOVATIONS
Status Date
Friday, June 18, 2021
Registration Number
4637897
Registration Date
Tuesday, November 11, 2014
Filing Date
Tuesday, April 2, 2013
Published for Opposition
Tuesday, February 25, 2014
Cancellation Date
Friday, June 18, 2021
35 Business management services for the pharmaceutical and medical device industries in connection with product development and program management, clinical trials, FDA approvals, and regulatory matters; Business management services for the biotech industry in connection with product development and program management, clinical trials, FDA approvals, and regulatory matters, all related to the medical or clinical treatment of illness or disease; business consulting services in conjunction with all of the foregoing
45 Regulatory compliance consulting services for the pharmaceutical and medical device industries related to product research and development, program management, clinical trials, FDA approvals, and regulatory matters; Regulatory compliance consulting services for the biotech industry related to product research and development, program management, clinical trials, FDA approvals, and regulatory matters, all related to the medical or clinical treatment of illness or disease; Technical consulting services for the pharmaceutical and medical device industries related to FDA approvals and regulatory matters; Technical consulting services for the biotech industry related to FDA approvals and regulatory matters, all related to the medical or clinical treatment of illness or disease
42 Research and development services for the pharmaceutical and medical device industries in connection with product development and program management, clinical trials, FDA approvals, and regulatory matters; Research and development services for the biotech industry in connection with product development and program management, clinical trials, FDA approvals, and regulatory matters, all related to the medical or clinical treatment of illness or disease; Technical consulting services for the pharmaceutical and medical device industries related to product research and development and clinical trials; Technical consulting services for the biotech industry related to product research and development and clinical trials, all related to the medical or clinical treatment of illness or disease; medical and pharmaceutical research services in the field of healthcare
Color is not claimed as a feature of the mark.
"DEVELOPMENT"
Jan 25, 2023
Assignment Of Ownership Not Updated Automatically
Jun 18, 2021
Cancelled Sec. 8 (6-Yr)
Apr 10, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Apr 10, 2020
Teas Change Of Correspondence Received
Apr 10, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Apr 10, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Apr 10, 2020
Teas Change Of Owner Address Received
Nov 11, 2019
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Nov 23, 2016
Assignment Of Ownership Not Updated Automatically
Nov 11, 2014
Registered-Principal Register
Oct 8, 2014
Notice Of Acceptance Of Statement Of Use E-Mailed
Oct 7, 2014
Allowed Principal Register - Sou Accepted
Sep 25, 2014
Statement Of Use Processing Complete
Sep 4, 2014
Use Amendment Filed
Sep 24, 2014
Case Assigned To Intent To Use Paralegal
Sep 4, 2014
Teas Statement Of Use Received
Sep 4, 2014
Teas Change Of Correspondence Received
Apr 22, 2014
Noa E-Mailed - Sou Required From Applicant
Feb 25, 2014
Official Gazette Publication Confirmation E-Mailed
Feb 25, 2014
Published For Opposition
Feb 5, 2014
Notification Of Notice Of Publication E-Mailed
Jan 17, 2014
Law Office Publication Review Completed
Jan 13, 2014
Assigned To Lie
Dec 16, 2013
Approved For Pub - Principal Register
Dec 2, 2013
Examiner's Amendment Entered
Dec 2, 2013
Notification Of Examiners Amendment E-Mailed
Dec 2, 2013
Examiners Amendment E-Mailed
Dec 2, 2013
Examiners Amendment -Written
Nov 19, 2013
Examiner's Amendment Entered
Nov 19, 2013
Notification Of Examiners Amendment E-Mailed
Nov 19, 2013
Examiners Amendment E-Mailed
Nov 19, 2013
Examiners Amendment -Written
Oct 30, 2013
Teas/Email Correspondence Entered
Oct 30, 2013
Correspondence Received In Law Office
Oct 30, 2013
Teas Response To Office Action Received
Jul 18, 2013
Notification Of Non-Final Action E-Mailed
Jul 18, 2013
Non-Final Action E-Mailed
Jul 18, 2013
Non-Final Action Written
Jul 15, 2013
Assigned To Examiner
Apr 8, 2013
New Application Office Supplied Data Entered
Trademark Alertz updated from USPTO on 2030-01-24
